Torsade de Pointes: Differential Diagnoses & Workup

References

1. Antzelevitch C. Brugada syndrome. Pacing Clin Electrophysiol. Oct 2006;29(10):1130-59. [Medline].

2. Pacha O, Kadikoy H, Amro M, Haque W, Abdellatif A. Torsades de pointes and prolonged QT syndrome in Takotsubo cardiomyopathy. J Cardiovasc Med (Hagerstown). Jan 13 2010;[Medline].

3. Alipour A, Cruz R, Lott RS. Torsade de pointes after ziprasidone overdose with coingestants. J Clin Psychopharmacol. Feb 2010;30(1):76-7. [Medline].

4. Dobesh PP, Trujillo TC. Ranolazine: a new option in the management of chronic stable angina. Pharmacotherapy. Dec 2007;27(12):1659-76. [Medline].

5. Brady W, Meldon S, DeBehnke D. Comparison of prehospital monomorphic and polymorphic ventricular tachycardia: prevalence, response to therapy, and outcome. Ann Emerg Med. Jan 1995;25(1):64-70. [Medline].

6. Brady WJ, DeBehnke DJ, Laundrie D. Prevalence, therapeutic response, and outcome of ventricular tachycardia in the out-of-hospital setting: a comparison of monomorphic ventricular tachycardia, polymorphic ventricular tachycardia, and torsades de pointes. Acad Emerg Med. Jun 1999;6(6):609-17. [Medline].

7. Chen CY, Wang FL, Lin CC. Chronic hydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia. Clin Toxicol (Phila). 2006;44(2):173-5. [Medline].

8. Delbridge TR, Yealy DM. Wide complex tachycardia. Emerg Med Clin North Am. Nov 1995;13(4):903-24. [Medline].

9. Fantoni M, Autore C, Del Borgo C. Drugs and cardiotoxicity in HIV and AIDS. Ann NY Acad Sci. 2001;946:179-99. [Medline].

10. Fung AY, Kerr CR, Maybee TK. QT prolongation and torsades de pointes: the sole manifestation of coronary artery disease. Int J Cardiol. Jan 1985;7(1):63-6. [Medline].

11. Jackson CW, Sheehan AH, Reddan JG. Evidence-based review of the black-box warning for droperidol. Am J Health Syst Pharm. Jun 1 2007;64(11):1174-86. [Medline].

12. Janeira LF. Torsades de pointes and long QT syndromes. Am Fam Physician. Oct 1995;52(5):1447-53. [Medline].

13. Kerr CR, Hacking A, Henning H. Effects of transient myocardial ischemia on the QT interval in man. Can J Cardiol. Nov-Dec 1987;3(8):383-6. [Medline].

14. Kerr CR, Klein GJ, Cooper JA, Sharma AD. Use of electrical pacemakers in the treatment of ventricular tachycardia and ventricular fibrillation. Cardiovasc Clin. 1985;16(1):215-37. [Medline].

15. Monraba R, Sala C. Percutaneous overdrive pacing in the out-of-hospital treatment of torsades de pointes [letter]. Ann Emerg Med. Mar 1999;33(3):356-7. [Medline].

16. Myerburg RJ, Interian A Jr, Mitrani RM, et al. Frequency of sudden cardiac death and profiles of risk. Am J Cardiol. Sep 11 1997;80(5B):10F-19F. [Medline].

17. Nordin C, Kohli A, Beca S. Importance of hepatitis C coinfection in the development of QT prolongation in HIV-infected patients. J Electrocardiol. Apr 2006;39(2):199-205. [Medline].

18. Poelzing S, Rosenbaum DS. Cellular mechanisms of Torsade de Pointes. Novartis Found Symp. 2005;266:204-17; discussion 217-24. [Medline].

19. Roden DM. A practical approach to torsade de pointes. Clin Cardiol. Mar 1997;20(3):285-90. [Medline].

20. Roden DM. Taking the "idio" out of "idiosyncratic": predicting torsades de pointes. Pacing Clin Electrophysiol. May 1998;21(5):1029-34. [Medline].

21. Roden DM, Anderson ME. The pause that refreshes, or does it? Mechanisms in torsades de pointes [editorial]. Heart. Sep 2000;84(3):235-7. [Medline].

22. Roden DM, Viswanathan PC. Genetics of acquired long QT syndrome. J Clin Invest. Aug 2005;115(8):2025-32. [Medline].

23. Schenck JB, Rizvi AA, Lin T. Severe primary hypothyroidism manifesting with torsades de pointes. Am J Med Sci. Mar 2006;331(3):154-6. [Medline].

24. Sticherling C, Schaer BA, Ammann P. Methadone-induced Torsade de pointes tachycardias. Swiss Med Wkly. May 14 2005;135(19-20):282-5. [Medline].

25. Tan HL, Hou CJ, Lauer MR, Sung RJ. Electrophysiologic mechanisms of the long QT interval syndromes and torsade de pointes. Ann Intern Med. May 1 1995;122(9):701-14. [Medline].

26. Tatetsu H, Asou N, Nakamura M. Torsades de pointes upon fluconazole administration in a patient with acute myeloblastic leukemia. Am J Hematol. Apr 20 2006;81(5):366-369. [Medline].

27. Viskin S, Fish R. Prevention of ventricular arrhythmias in the congenital long QT syndrome [In Process Citation]. Curr Cardiol Rep. Nov 2000;2(6):492-7. [Medline].

28. Viskin S, Glikson M, Fish R, et al. Rate smoothing with cardiac pacing for preventing torsade de pointes. Am J Cardiol. Nov 2 2000;86(9A):111K-115K. [Medline].

29. Vodoz JF, Jaquier F, Lamy O. [Torsade de pointes: a severe and unknown adverse effect in a patient taking methadone]. Schweiz Rundsch Med Prax. Oct 8 2003;92(41):1748-50. [Medline].

30. Vukmir RB. Torsades de Pointes: a review. Am J Emerg Med. May 1991;9(3):250-5. [Medline].

31. Wang SH, Lin CY, Huang TY. QT interval effects of cisapride in the clinical setting. Int J Cardiol. 2001;80 (2-3):179-83. [Medline].

32. Wisialowski TA, Crimin KS, Engtrakul J. Differentiation of arrhythmia risk of the antibacterials moxifloxacin, erythromycin and telithromycin based on analysis of MAPD alternans and cardiac instability. J Pharmacol Exp Ther. Apr 13 2006;[Medline].

33. Witchel HJ, Hancox JC. Familial and acquired long qt syndrome and the cardiac rapid delayed rectifier potassium current. Clin Exp Pharmacol Physiol. Oct 2000;27(10):753-66. [Medline].

34. Yearly DM, Stapcynshi JS. Dysrhythmias. In: Rosen P, Barkin RM, Braen GR, eds. Emergency Medicine: Concepts and Clinical Practice. 3^rd ed. Mosby-Year Book; 1992.

Further Reading

Keywords

torsade de pointes, TDP, torsade, ventricular tachycardia, VT, polymorphous VT, twisting of the point, cardiac syncope, vasovagal syncope, QT syndrome, QT interval, sudden death, unstable heart beat rhythm, TDP rhythm, dysrhythmia, Brugada syndrome

Contributor Information and Disclosures

Author

Michael J Bessette, MD, FACEP, Director of Emergency Medicine, Jersey City Medical Center
Michael J Bessette, MD, FACEP is a member of the following medical societies: American College of Emergency Physicians
Disclosure: Nothing to disclose.

Coauthor(s)

Sheldon Jacobson, MD, Chair, Professor, Department of Emergency Medicine, Mount Sinai Medical Center
Sheldon Jacobson, MD is a member of the following medical societies: American College of Emergency Physicians and American College of Physicians
Disclosure: Nothing to disclose.

Medical Editor

Theodore J Gaeta, DO, MPH, FACEP, Clinical Associate Professor, Department of Emergency Medicine, Joan and Sanford Weill Medical College at Cornell University; Vice Chairman and Program Director of Emergency Medicine Residency Program, Department of Emergency Medicine, New York Methodist Hospital; Academic Chair, Adjunct Professor, Department of Emergency Medicine, St George's University School of Medicine
Theodore J Gaeta, DO, MPH, FACEP is a member of the following medical societies: Alliance for Clinical Education, American College of Emergency Physicians, Clerkship Directors in Emergency Medicine, Council of Emergency Medicine Residency Directors, New York Academy of Medicine, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Gary Setnik, MD, Chair, Department of Emergency Medicine, Mount Auburn Hospital; Assistant Professor, Division of Emergency Medicine, Harvard Medical School
Gary Setnik, MD is a member of the following medical societies: American College of Emergency Physicians, National Association of EMS Physicians, and Society for Academic Emergency Medicine
Disclosure: SironaHealth Salary Management position; South Middlesex EMS Consortium Salary Management position

CME Editor

John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Chief Editor

David FM Brown, MD, Assistant Professor, Division of Emergency Medicine, Harvard Medical School; Vice Chair, Department of Emergency Medicine, Massachusetts General Hospital
David FM Brown, MD is a member of the following medical societies: American College of Emergency Physicians and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.